The TCW Concentrated Large Cap Growth Fund Q3 2026 Commentary details tech sector performance and strategic stock holdings.

Total revenue increased 7% to a record $11.0M from $10.2M in the same prior year period. During 2026, the Company has reduced ...

MotorK PLC (AMS: MTRK) ("MotorK", the "Group" or the "Company"), a leading SaaS provider to the automotive retail industry in the EMEA region, today announced its financial results for the nine months ...

VERIMATRIX (Euronext Paris: VMX, FR0010291245), a leading provider of user-centric security solutions for a safer connected world, announces its third-quarter revenue for fiscal year 2026 (July 1 to ...

AudioEye Q3 2026 revenue reached a record $11 million as adjusted EBITDA rose 58%. Management raised full-year EBITDA ...

ArriVent BioPharma, Inc. announced initial Phase 1 results for ARR-217 (MRG007), a cadherin-17-targeting antibody-drug conjugate developed in partnership with Lepu Biopharma Co., Ltd. The data, ...

ArriVent BioPharma (NASDAQ:AVBP) delivered early oncology updates with initial Phase 1 results for ARR-217, an investigational antibody-drug conjugate targeting cadherin-17 (CDH17). The candidate, ...

Novartis' oral BTK inhibitor remibrutinib (Rhapsido) met its primary endpoint in Phase III REMODEL-1 and REMODEL-2 relapsing ...

Responses were deep and durable, with 65% ongoing at clinical cutoff; Results support continued evaluation of the ...

ORR at 6mg/kg dose in late-line CRC patients ARR-217 was generally well-tolerated ArriVent to host virtual webinar on Monday, ...

Celebrate our nation’s 250th birthday with a full slate of patriotic music during the Rogue Valley Symphonic Band’s 2026-27 ...

Gagan Sharma appointed as President, Specialty Business at Evonile Pharma Limited. Designated as Senior Management Personnel ...